The CD38 antibody portion of the immunocytokine would, however, direct a high local concentration of attenuated IFNα to the surface of CD38 positive tumor cells (Fig 2A, upper diagram), thereby compensating for the weakened binding of IFNα to IFNAR and restoring activity on the targeted tumor cells. This evidence concerns the gene IFNA2 and neoplasm.